Reply to: Letter regarding the study by Nilsen et al. on IL-1RA and 5-Year Mortality Risk: Redefining the Threshold for high admission levels of IL-1RA

Affiliations

¹ Stavanger University Hospital, Department of Cardiology, Stavanger, Norway; University of Bergen, Department of Clinical Science, Bergen, Norway. Electronic address: nide@sus.no.
² Stavanger University Hospital, Department of Cardiology, Stavanger, Norway; Hospital Papa Francisco, Internal Medicine Program, Salta, Argentina; Cardiovascular Center of Salta, Department of Cardiology, Salta, Argentina.
³ Cardiovascular Center of Salta, Department of Cardiology, Salta, Argentina.
⁴ Stavanger University Hospital, Department of Cardiology, Stavanger, Norway.
⁵ University of Oslo, Faculty of Medicine, Oslo, Norway; Oslo University Hospital, Rikshospitalet, Research Institute of Internal Medicine, Oslo, Norway.
⁶ University of Oslo, Faculty of Medicine, Oslo, Norway; Oslo University Hospital, Rikshospitalet, Research Institute of Internal Medicine, Oslo, Norway; Oslo University Hospital, Rikshospitalet, Section of Clinical Immunology and Infectious Diseases, Oslo, Norway.
⁷ Sigma Statistical Services, Balmullo, United Kingdom of Great Britain and Northern Ireland.
⁸ University of Oslo, Faculty of Medicine, Oslo, Norway; Oslo University Hospital, Rikshospitalet, Research Institute of Internal Medicine, Oslo, Norway; Thrombosis Research Center (TREC), Division of Internal Medicine, University Hospital of Northern Norway, Tromsø, Norway.

D W T Nilsen et al. Int J Cardiol. 2025.

. 2025 Dec 15:441:133806.

doi: 10.1016/j.ijcard.2025.133806. Epub 2025 Aug 19.

¹ Stavanger University Hospital, Department of Cardiology, Stavanger, Norway; University of Bergen, Department of Clinical Science, Bergen, Norway. Electronic address: nide@sus.no.
² Stavanger University Hospital, Department of Cardiology, Stavanger, Norway; Hospital Papa Francisco, Internal Medicine Program, Salta, Argentina; Cardiovascular Center of Salta, Department of Cardiology, Salta, Argentina.
³ Cardiovascular Center of Salta, Department of Cardiology, Salta, Argentina.
⁴ Stavanger University Hospital, Department of Cardiology, Stavanger, Norway.
⁵ University of Oslo, Faculty of Medicine, Oslo, Norway; Oslo University Hospital, Rikshospitalet, Research Institute of Internal Medicine, Oslo, Norway.
⁶ University of Oslo, Faculty of Medicine, Oslo, Norway; Oslo University Hospital, Rikshospitalet, Research Institute of Internal Medicine, Oslo, Norway; Oslo University Hospital, Rikshospitalet, Section of Clinical Immunology and Infectious Diseases, Oslo, Norway.
⁷ Sigma Statistical Services, Balmullo, United Kingdom of Great Britain and Northern Ireland.
⁸ University of Oslo, Faculty of Medicine, Oslo, Norway; Oslo University Hospital, Rikshospitalet, Research Institute of Internal Medicine, Oslo, Norway; Thrombosis Research Center (TREC), Division of Internal Medicine, University Hospital of Northern Norway, Tromsø, Norway.

No abstract available

Publication types